1. Hematologic remission and cytogenetic improvement induced by recombinant interferon alfa A in chronic myelogenous leukemia;Talpaz, M.; Kantarjian, H.M.; McCredie, K.; Trujillo, J.M.; Keating, M.J.; Gutterman, J.U.;N EnglJf Med,1986
2. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon alfa-2b. Semin Oncol;Colomb, H.M.; Fefer, A.; Golde, D.W.; Ozer, H.; Portlock, C.; Silber, R.,1988
3. A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy. Am7Clin Oncol;Clark, R.H.; Dimitrov, N.V.; Axelson, J.A.; Charamella, L.J.; Stott, P.B.,1989
4. Role of interferons in the therapy of melanoma;Kirkwood, J.M.; Ernstoff, M.S.;J Invest Dermatol,1990
5. Clinical evaluation of interferons in malignant melanoma;McLeod, G.R.; Thomson, D.B.; Hersey, P.;J Invest Dermatol,1990